DE69306250D1 - Ein verfahren zur bestimmung des biologischen potentials eines ausgenählten karzinoms von einem patienten - Google Patents

Ein verfahren zur bestimmung des biologischen potentials eines ausgenählten karzinoms von einem patienten

Info

Publication number
DE69306250D1
DE69306250D1 DE69306250T DE69306250T DE69306250D1 DE 69306250 D1 DE69306250 D1 DE 69306250D1 DE 69306250 T DE69306250 T DE 69306250T DE 69306250 T DE69306250 T DE 69306250T DE 69306250 D1 DE69306250 D1 DE 69306250D1
Authority
DE
Germany
Prior art keywords
carcinoma
patient
estimating
biopsy
potential
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69306250T
Other languages
English (en)
Other versions
DE69306250T2 (de
Inventor
Michael K Brawer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Washington
Original Assignee
University of Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington filed Critical University of Washington
Application granted granted Critical
Publication of DE69306250D1 publication Critical patent/DE69306250D1/de
Publication of DE69306250T2 publication Critical patent/DE69306250T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G01N33/5017—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
DE69306250T 1992-01-15 1993-01-15 Ein verfahren zur bestimmung des biologischen potentials eines ausgenählten karzinoms von einem patienten Expired - Fee Related DE69306250T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82112092A 1992-01-15 1992-01-15
PCT/US1993/000449 WO1993014407A1 (en) 1992-01-15 1993-01-15 A method for estimating the biologic potential of a selected carcinoma in a patient

Publications (2)

Publication Number Publication Date
DE69306250D1 true DE69306250D1 (de) 1997-01-09
DE69306250T2 DE69306250T2 (de) 1997-03-20

Family

ID=25232578

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69306250T Expired - Fee Related DE69306250T2 (de) 1992-01-15 1993-01-15 Ein verfahren zur bestimmung des biologischen potentials eines ausgenählten karzinoms von einem patienten

Country Status (11)

Country Link
US (2) US5688694A (de)
EP (1) EP0643839B1 (de)
JP (1) JPH07503069A (de)
AT (1) ATE145728T1 (de)
AU (1) AU673153B2 (de)
CA (1) CA2128031A1 (de)
DE (1) DE69306250T2 (de)
ES (1) ES2095038T3 (de)
FI (1) FI943355A (de)
NO (1) NO942653L (de)
WO (1) WO1993014407A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1158047B1 (de) * 1999-03-05 2009-05-20 Mitsubishi Rayon Co., Ltd. Microarray mit einer biologischen substanz
DE60141567D1 (de) 2000-01-25 2010-04-29 Edwards Lifesciences Corp Freisetzungssysteme zur behandlung von restenose und anastomotischer intimaler hyperplasie
AU1782102A (en) 2000-11-06 2002-05-15 Univ Texas Laser scanning cytometry mediated analysis of therapeutic efficacy in tumors
US6993175B2 (en) * 2001-09-07 2006-01-31 Quest Diagnostics Investments Incorporated Methods for measuring microvascular density in tumors
US7229423B2 (en) * 2003-02-05 2007-06-12 Timi 3 System, Inc Systems and methods for applying audible acoustic energy to increase tissue perfusion and/or vasodilation
US20070100335A1 (en) * 2005-10-28 2007-05-03 Apple Medical Corporation Instrument for electrosurgical excision procedure for the uterine cervix
US8321010B2 (en) * 2009-09-04 2012-11-27 Konstantin Georgievich Korotkov Method for determining the condition of a biological object and device for making same
FR2964744B1 (fr) * 2010-09-10 2015-04-03 Univ Versailles St Quentin En Yvelines Test pronostic de l'evolution d'une tumeur solide par analyse d'images

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992007259A1 (en) * 1990-10-16 1992-04-30 Biomedical Frontiers, Inc. Polymer-deferoxamine-ferric iron adducts for use in magnetic resonance imaging

Also Published As

Publication number Publication date
FI943355A0 (fi) 1994-07-14
US5688694A (en) 1997-11-18
WO1993014407A1 (en) 1993-07-22
US5616469A (en) 1997-04-01
AU673153B2 (en) 1996-10-31
NO942653D0 (no) 1994-07-14
EP0643839B1 (de) 1996-11-27
JPH07503069A (ja) 1995-03-30
NO942653L (no) 1994-09-12
EP0643839A1 (de) 1995-03-22
DE69306250T2 (de) 1997-03-20
FI943355A (fi) 1994-09-14
ATE145728T1 (de) 1996-12-15
AU3478293A (en) 1993-08-03
CA2128031A1 (en) 1993-07-22
ES2095038T3 (es) 1997-02-01

Similar Documents

Publication Publication Date Title
ATE130104T1 (de) Verfahren zur bestimmung von hdl-cholesterin mittels eines schnelldiagnostikums mit integriertem fraktionierschritt.
ATE333517T1 (de) Verfahren und sondenset zur erkennung von krebs
EP1496350A3 (de) Verfahren und Vorrichtung zum Erzeugen von Basissätzen für Spektralanalyse
EP1254630A3 (de) Verfahren, Vorrichtung und Computerprogramm zur Bestimmung des Blutflusses in einer Gewebe- oder Organregion
DE69306250T2 (de) Ein verfahren zur bestimmung des biologischen potentials eines ausgenählten karzinoms von einem patienten
Beaufort-Murphy The seed surface morphology of the Gesneriaceae utilizing the scanning electron microscope and a new system for diagnosing seed morphology.
ATE282831T1 (de) Verfahren zur diagnose von sepsis unter bestimmung löslicher cytokeratinfragmente
ATE318930T1 (de) Nukleinsäuresonden zur detektion von candida- spezies
DE59009364D1 (de) Verfahren zur quantitativen Bestimmung zumindest eines chemischen Parameters eines Probenmediums.
DE50105971D1 (de) Verfahren zur Diagnose von Sepsis unter Bestimmung von CA 125
ATE220209T1 (de) Diagnostisches verfahren zur bestimmung der ätiologie entzündlicher prozesse
ATE130100T1 (de) Verfahren zur immunologischen erkennung maligner tumore und kit zur durchführung dieses verfahrens.
RU2007148219A (ru) Способ обнаружения бактерий и тест-набор для их обнаружения
DE69618991T2 (de) Ein verfahren zur bestimmung der konzentration von sauerstoff in einer probe
DE69719091D1 (de) Verfahren zur objektivierung von subjektiven klassifizierungen
DE3585562D1 (de) Verfahren zur optischen untersuchungsanalyse von integrierten schaltungen.
Skog Loxsomopteris anasilla, a new fossil fern rhizome from the Cretaceous of Maryland
Till The share of southeastern black counties in the southern rural renaissance: were they bypassed by factory job gains, 1959-77?
Marshall Interior Rim Impressions as an Indicator of Typological Relationships
ATE458813T1 (de) Verfahren zur bestimmung von ctp11 sowie zur bestimmung des metastatischen potentials einer tumor probe
Turner Sponge gemmules from lake sediments in the Puget Lowland, Washington
DE3769560D1 (de) Verfahren zur ermittlung von kernmagnetischen spektren aus raeumlich selektierbaren bereichen eines untersuchungsobjektes.
Orser et al. Using Ari Kara Osteological Data To Evaluate An Assumpti on oF Fur Trade Archaeology
Grant Right Place, Time and Technique: Right Sample.
Balbi et al. Method for the Determination of Nonmetallic Inclusions

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee